Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Paxlovid”

Showing 17 of 0 results

Not applicableStudy completedNCT06076863
What this trial is testing

Pharmacist Management of Paxlovid eVisits

Who this might be right for
COVID-19Quality of Care
Kaiser Permanente 2,478
Not applicableStudy completedNCT05618600
What this trial is testing

Scripps-eMed Covid-19 Study: A Prospective Monitoring Study for Those Individuals Treated With Paxlovid

Who this might be right for
COVID-19
Scripps Translational Science Institute 917
Not applicableUnknownNCT05996770
What this trial is testing

Evaluation of the Safety and Efficacy of Azvudine and Paxlovid in the Treatment of Hospitalized Patients With COVID-19

Who this might be right for
PaxlovidAzvudineCOVID-19
Xiao Li，MD 1,500
Testing effectiveness (Phase 2)WithdrawnNCT05545319
What this trial is testing

Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Coronavirus Disease 2019 (COVID-19)Immunocompromised+2 more
Pfizer
Not applicableLooking for participantsNCT05387369
What this trial is testing

A Real World Study of Paxlovid for the Treatment of Hospitalized Patients Confirmed With COVID-19

Who this might be right for
COVID-19
Huashan Hospital 2,000
Large-scale testing (Phase 3)Study completedNCT05341609
What this trial is testing

Efficacy and Safety of JT001 (VV116) Compared With Paxlovid

Who this might be right for
COVID-19
Vigonvita Life Sciences 822
Not applicableStudy completedNCT07089680
What this trial is testing

Learn About the Study Medicine Paxlovid (Nirmatrelvir + Ritonavir) in Adults Aged 60 and Older Living in Korean Long-term Care Hospitals Who Have COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
Pfizer 937
Not applicableStudy completedNCT07072793
What this trial is testing

A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High Chances of the Disease Becoming Severe

Who this might be right for
COVID-19 (Coronavirus Disease 2019)
Pfizer 131,005
Early research (Phase 1)Study completedNCT05898672
What this trial is testing

Learn About the Study Medicine Called Nirmatrelvir/Ritonavir in People Who Are Healthy Volunteers Co-administered the Medicine Rosuvastatin

Who this might be right for
PharmacokineticsHealthy Volunteers
Pfizer 12
Not applicableUnknownNCT05532852
What this trial is testing

Efficacy and Safety Evaluation of Paxlovid for COVID-19: a Real-world Case-control Study

Who this might be right for
COVID-19 Pneumonia
Ruijin Hospital 728
Not applicableStudy completedNCT05263908
What this trial is testing

Learn About PAXLOVID (a Commercial Medicine) In People With COVID-19

Who this might be right for
SARS-CoV-2 Infection
Pfizer 3,346
Not applicableLooking for participantsNCT05890612
What this trial is testing

A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in Patients Who Have a High Chance of Getting Severe COVID-19

Who this might be right for
COVID-19
Pfizer 3,000
Early research (Phase 1)Study completedNCT05491330
What this trial is testing

Bioequivalence Study of Nirmatrelvir & Ritonavir From Copaxid 150 +100 mg Tablets (Eva Pharma, Egypt) Versus Paxlovid 150 + 100 mg Film Coated Tablets (Pfizer Europe, Belgium)

Who this might be right for
Healthy
Genuine Research Center, Egypt 28
Not applicableStudy completedNCT04550936
What this trial is testing

Understand How the Use of Paxlovid Affected the Healthcare Use in People With Pre-existing Conditions.

Who this might be right for
Invasive AspergillosisMucormycosis
Pfizer 307
Early research (Phase 1)Ended earlyNCT05487040
What this trial is testing

Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

Who this might be right for
COVID-19
Pfizer 15
Early research (Phase 1)WithdrawnNCT06397144
What this trial is testing

A Study on 2 Different Combination Tablets of Nirmatrelvir Plus Ritonavir to Compare Them With Marketed Paxlovid in Healthy Participants

Who this might be right for
Biological AvailabilityHealthy Participants
Pfizer
Not applicableStudy completedNCT07090486
What this trial is testing

Understand How the Use of Paxlovid Affected Healthcare Use in People With Pre-existing Conditions.

Who this might be right for
COVID-19
Pfizer 14,000

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation